TOP TREI

Terapia-Ranbaxy

COTA DE PIATA: 4,5%

VANZARI IN ROMANIA: circa 75 mil. euro*

 

Zentiva-Sicomed

COTA DE PIATA: 5,9%

VANZARI IN ROMANIA: 63 mil. euro

 

Sandoz

COTA DE PIATA: 3,3%

VANZARI IN ROMANIA: 41,2 mil. euro

 


cifrele sunt valabile pentru 2005;

*include si activitatea de distributie

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *